Exclusive: Nvidia and Unity join Emulate’s $700m fundraise | Sifted
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Emulate, a London-based company spun out of DeepMind, has raised $700 million in a funding round backed by Unity and NVentures, the investment arm of Nvidia, valuing the business at $8.8 billion. The deal adds two strategic investors with deep ties to the AI and gaming software ecosystems to Emulate’s cap table, alongside earlier backing that included a $495 million raise at a $2.5 billion valuation. Emulate is developing a “virtual cell” model of human biology, an AI-driven simulation platform that Chief Executive Officer David Nitch-Smith-Rogers said aims to predict how drugs behave in the body. The company’s technology is positioned as a faster, cheaper alternative to laboratory testing, a market where drug developers spend heavily on preclinical research. The new capital will fund expansion of Emulate’s platform and commercial push into pharma R&D; watch for adoption announcements with large drugmakers and whether the company can convert pilot programs into recurring revenue.
Muhabbit's AI wrote this summary in its own words from Sifted's report. It can get details wrong, so check the source.
Named in this story
Emulate, Nvidia (NVDA), Unity, NVentures, London
A linked name opens that asset's sentiment page.